Delicate percutaneous renal artery stenting minimizes postoperative renal injury and protects kidney in patients with severe atherosclerotic renal artery stenosis and impaired renal function

International Heart Journal

Volumn 46, Issue 6, 2005, Pages 1061-1072

  Tsao, Chen Rong ^a,b   Lee, Wen Lieng ^a,b,d   Liu, Tsun Jui ^a,b   Chen, Ying Tsung ^a,c   Ting, Chih Tai ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d Division of Cardiology   (Taiwan)

Author keywords

Percutaneous transluminal angioplasty; Renal artery stenosis; Stent

Indexed keywords

CREATININE;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; KIDNEY ARTERY EMBOLISM; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY INJURY; MALE; NEPHROSCLEROSIS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL PROTECTION; STENT; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE; ARTERIOSCLEROSIS; BLOOD; BLOOD PRESSURE; KIDNEY; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENAL ARTERY;

AGED; ANGIOPLASTY, BALLOON; ARTERIOSCLEROSIS; BLOOD PRESSURE; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; MALE; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; STENTS;

EID: 30444444059     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.46.1061     Document Type: Article

References (36)

1. Bakker J, Goffette PP, Henry M, et al. The Erasme study: a multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc Intervent Radiol 1999; 22: 468-74.
2. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJM 1999; 92: 159-67. (Review)
3. Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001; 142: 314-23.
4. Zeller T, Frank U, Muller C, et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther 2004; 11: 95-106.
5. Lim ST, Rosenfield K. Renal artery stent placement Indications and results. Curr Interv Cardiol Rep 2000; 2: 130-9.
6. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism - a critical review. Am J Kidney Dis 1994; 24: 713-27. (Review)
7. Krishnamurthi V, Novick AC, Myles JL. Atheroembolic renal disease: effect on morbidity and survival after revascularization for atherosclerotic renal artery stenosis. J Urol 1999; 161: 1093-6.
8. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-9.
9. Gerlach AT, Pickworth KK. Contrast medium-induced nephrotoxicity: pathophysiology and prevention. Pharmacotherapy 2000; 20: 540-8. (Review)
10. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254-61.
11. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-20.
12. Grube E, Gerckens U, Yeung AC, et al. Prevention of distal embolization during coronary angioplasty in saphenous vein grafts and native vessels using porous filter protection. Circulation 2001; 104: 2436-41.
13. Al-Mubarak N, Colombo A, Gaines PA, et al. Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol 2002; 39: 841-6.
14. Henry M, Henry I, Klonaris C, et al. Renal angioplasty and stenting under protection: the way for the future? Catheter Cardiovasc Interv 2003; 60: 299-312.
15. Li SS, Wong CH, Lam CW. Renal angioplasty under protection of the PercuSurge GuardWire Plus System. J Invasive Cardiol 2003; 15: 148-50.
16. Novick A. Patient selection for intervention to preserve renal function in ischemic renal disease. In: Novick A, Scoble J, Hamilton G, eds. Renal Vascular Disease. W.B. Saunders; 1996: 323-34.
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
18. Boisclair C, Therasse E, Oliva VL, et al. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: midterm technical and clinical results. AJR Am J Roentgenol 1997; 168: 245-51.
19. Rodriguez-Lopez JA, Werner A, Ray LI, et al. Renal artery stenosis treated with stent deployment: indications, technique, and outcome for 108 patients. J Vasc Sing 1999; 29: 617-24.
20. Beutler JJ, Van Ampting JM, Van De Ven PJ, et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 2001; 12: 1475-81.
21. Paulsen D, Klow NE, Rogstad B, et al. Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease. Nephrol Dial Transplant 1999; 14: 1454-61.
22. Gill KS, Fowler RC. Atherosclerotic renal arterial stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology 2003; 226: 821-6.
23. Bush RL, Najibi S, MacDonald MJ, et al. Endovascular revascularization of renal artery stenosis: technical and clinical results. J Vasc Surg 2001; 33: 1041-9.
24. Taylor A, Sheppard D, Macleod MJ, et al. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin Radiol 1997; 52: 451-7.
25. Dorros G, Jaff M, Jain A, Dufek C, Mathiak L. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 1995; 75: 1051-5.
26. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-7.
27. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98: 642-7.
28. Ramos F, Kotliar C, Alvarez D, et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int 2003; 63: 276-82.
29. Chatziioannou A, Mourikis D, Agroyannis B, et al. Renal artery stenting for renal insufficiency in solitary kidney in 26 patients. Eur J Vasc Endovasc Surg 2002; 23: 49-54.
30. Wengrovitz M, Healy DA, Diamond JR, Atnip RG Renal revascularization in patients on dialysis. J Cardiovasc Surg (Torino) 1995; 36: 241-6.
31. Ivanovic V, McKusick MA, Johnson CM 3rd, et al. Renal artery stent placement: complications at a single tertiary care center. J Vasc Interv Radiol 2003; 14: 217-25.
32. Henry M, Amor K, Henry I, et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg 1999; 6: 42-51.
33. Scolari F, Bracchi M, Valzorio, B, et al. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant 1996; 11: 1607-12.
34. Mayo RR, Swartz RD. Redefining the incidence of clinically detectable atheroembolism. Am J Med 1996; 100: 524-9.
35. Wilms GE, Peene PT, Baert AL, et al. Renal artery stent placement with use of the Wallstent endoprosthesis. Radiology 1991; 179: 457-62.
36. Henry M, Klonaris C, Henry I, et al. Protected renal stenting with the PercuSurge GuardWire device: a pilot study. J Endovasc Ther 2001; 8: 227-37.